290 related articles for article (PubMed ID: 32835666)
1. Sex differences underlying preexisting cardiovascular disease and cardiovascular injury in COVID-19.
Medzikovic L; Cunningham CM; Li M; Amjedi M; Hong J; Ruffenach G; Eghbali M
J Mol Cell Cardiol; 2020 Nov; 148():25-33. PubMed ID: 32835666
[TBL] [Abstract][Full Text] [Related]
2. COVID-19 and cardiovascular diseases.
Liu F; Liu F; Wang L
J Mol Cell Biol; 2021 Jul; 13(3):161-167. PubMed ID: 33226078
[TBL] [Abstract][Full Text] [Related]
3. Sex differences in COVID-19: candidate pathways, genetics of ACE2, and sex hormones.
Viveiros A; Rasmuson J; Vu J; Mulvagh SL; Yip CYY; Norris CM; Oudit GY
Am J Physiol Heart Circ Physiol; 2021 Jan; 320(1):H296-H304. PubMed ID: 33275517
[TBL] [Abstract][Full Text] [Related]
4. Organ-protective effect of angiotensin-converting enzyme 2 and its effect on the prognosis of COVID-19.
Cheng H; Wang Y; Wang GQ
J Med Virol; 2020 Jul; 92(7):726-730. PubMed ID: 32221983
[TBL] [Abstract][Full Text] [Related]
5. The Science Underlying COVID-19: Implications for the Cardiovascular System.
Liu PP; Blet A; Smyth D; Li H
Circulation; 2020 Jul; 142(1):68-78. PubMed ID: 32293910
[TBL] [Abstract][Full Text] [Related]
6. COVID-19 as a viral functional ACE2 deficiency disorder with ACE2 related multi-organ disease.
Gan R; Rosoman NP; Henshaw DJE; Noble EP; Georgius P; Sommerfeld N
Med Hypotheses; 2020 Nov; 144():110024. PubMed ID: 32758871
[TBL] [Abstract][Full Text] [Related]
7. Endothelialitis plays a central role in the pathophysiology of severe COVID-19 and its cardiovascular complications.
Vrints CJM; Krychtiuk KA; Van Craenenbroeck EM; Segers VF; Price S; Heidbuchel H
Acta Cardiol; 2021 Apr; 76(2):109-124. PubMed ID: 33208052
[TBL] [Abstract][Full Text] [Related]
8. Latin-American Registry of Cardiovascular Disease and COVID-19: Rationale and Design of the CARDIO COVID 19-20 Registry.
Gómez-Mesa JE; Galindo-Coral S; Montes MC; Alarco W; Barisani JL; Magaña A; Perna ER; Romero A; Speranza M; Mendoza I; Wyss F
Glob Heart; 2021 Feb; 16(1):14. PubMed ID: 33833938
[TBL] [Abstract][Full Text] [Related]
9. Cardiovascular disease and COVID-19: a consensus paper from the ESC Working Group on Coronary Pathophysiology & Microcirculation, ESC Working Group on Thrombosis and the Association for Acute CardioVascular Care (ACVC), in collaboration with the European Heart Rhythm Association (EHRA).
Cenko E; Badimon L; Bugiardini R; Claeys MJ; De Luca G; de Wit C; Derumeaux G; Dorobantu M; Duncker DJ; Eringa EC; Gorog DA; Hassager C; Heinzel FR; Huber K; Manfrini O; Milicic D; Oikonomou E; Padro T; Trifunovic-Zamaklar D; Vasiljevic-Pokrajcic Z; Vavlukis M; Vilahur G; Tousoulis D
Cardiovasc Res; 2021 Dec; 117(14):2705-2729. PubMed ID: 34528075
[TBL] [Abstract][Full Text] [Related]
10. Cardiovascular Outcomes in the Acute Phase of COVID-19.
Nakano H; Shiina K; Tomiyama H
Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33920790
[TBL] [Abstract][Full Text] [Related]
11. The cardiovascular disorders and prognostic cardiac biomarkers in COVID-19.
Shi X; Chen M; Zhang Y
Mol Biol Rep; 2021 Feb; 48(2):1763-1771. PubMed ID: 33483864
[TBL] [Abstract][Full Text] [Related]
12. SARS-CoV-2 cell entry receptor ACE2 mediated endothelial dysfunction leads to vascular thrombosis in COVID-19 patients.
Kumar A; Narayan RK; Kumari C; Faiq MA; Kulandhasamy M; Kant K; Pareek V
Med Hypotheses; 2020 Dec; 145():110320. PubMed ID: 33032170
[TBL] [Abstract][Full Text] [Related]
13. Impact of Cardiovascular Risk Factors and Cardiovascular Diseases on Outcomes in Patients Hospitalized with COVID-19 in Daegu Metropolitan City.
Park BE; Lee JH; Park HK; Kim HN; Jang SY; Bae MH; Yang DH; Park HS; Cho Y; Lee BY; Nam CW; Lee JB; Kim U; Chae SC;
J Korean Med Sci; 2021 Jan; 36(2):e15. PubMed ID: 33429474
[TBL] [Abstract][Full Text] [Related]
14. COVID-19 and Individual Genetic Susceptibility/Receptivity: Role of ACE1/ACE2 Genes, Immunity, Inflammation and Coagulation. Might the Double X-chromosome in Females Be Protective against SARS-CoV-2 Compared to the Single X-Chromosome in Males?
Gemmati D; Bramanti B; Serino ML; Secchiero P; Zauli G; Tisato V
Int J Mol Sci; 2020 May; 21(10):. PubMed ID: 32423094
[TBL] [Abstract][Full Text] [Related]
15. COVID-19 and cardiovascular disease: a review of current knowledge.
Pal A; Ahirwar AK; Sakarde A; Asia P; Gopal N; Alam S; Kaim K; Ahirwar P; Sorte SR
Horm Mol Biol Clin Investig; 2021 Feb; 42(1):99-104. PubMed ID: 33544511
[TBL] [Abstract][Full Text] [Related]
16. Relationship Between Preexisting Cardiovascular Disease and Death and Cardiovascular Outcomes in Critically Ill Patients With COVID-19.
Vasbinder A; Meloche C; Azam TU; Anderson E; Catalan T; Shadid H; Berlin H; Pan M; O'Hayer P; Padalia K; Blakely P; Khaleel I; Michaud E; Huang Y; Zhao L; Pop-Busui R; Gupta S; Eagle K; Leaf DE; Hayek SS;
Circ Cardiovasc Qual Outcomes; 2022 Oct; 15(10):e008942. PubMed ID: 36193749
[TBL] [Abstract][Full Text] [Related]
17. Cardiovascular Implications of Fatal Outcomes of Patients With Coronavirus Disease 2019 (COVID-19).
Guo T; Fan Y; Chen M; Wu X; Zhang L; He T; Wang H; Wan J; Wang X; Lu Z
JAMA Cardiol; 2020 Jul; 5(7):811-818. PubMed ID: 32219356
[TBL] [Abstract][Full Text] [Related]
18. The Centrality of Obesity in the Course of Severe COVID-19.
Liu D; Zhang T; Wang Y; Xia L
Front Endocrinol (Lausanne); 2021; 12():620566. PubMed ID: 33776917
[TBL] [Abstract][Full Text] [Related]
19. Role of angiotensin-converting enzyme 2 in neurodegenerative diseases during the COVID-19 pandemic.
Li Z; Xu X; Yang M; Feng J; Liu C; Yang C
Aging (Albany NY); 2020 Nov; 12(23):24453-24461. PubMed ID: 33197881
[TBL] [Abstract][Full Text] [Related]
20. Coronavirus Disease 2019 and the Cerebrovascular-Cardiovascular Systems: What Do We Know So Far?
Larson AS; Savastano L; Kadirvel R; Kallmes DF; Hassan AE; Brinjikji W
J Am Heart Assoc; 2020 Jul; 9(13):e016793. PubMed ID: 32393136
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
